Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2008 | 09-2008 | 06-2008 | 03-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 183,546 | 109,339 | 77,338 | 199,013 | 57,339 |
| Receivables | 112,417 | 111,081 | 108,126 | 106,880 | 103,539 |
| Inventories | 146,103 | 155,615 | 149,345 | 144,037 | 144,535 |
| Income taxes - deferred | 24,135 | 21,234 | 21,214 | 25,075 | 22,254 |
| TOTAL | $497,392 | $436,282 | $379,561 | $489,323 | $339,931 |
| Non-Current Assets | |||||
| PPE Net | 76,003 | 69,999 | 63,437 | 63,344 | 61,730 |
| Intangibles | 438,092 | 419,840 | 402,608 | 406,509 | 403,204 |
| Other Non-Current Assets | 14,527 | 34,624 | 16,848 | 13,480 | 13,147 |
| TOTAL | $528,622 | $524,463 | $482,893 | $483,333 | $478,081 |
| Total Assets | $1,026,014 | $960,745 | $862,454 | $972,656 | $818,012 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 119,380 | 119,962 |
| Accounts payable and accrued liabilities | 22,964 | 26,083 | 26,029 | 26,365 | 23,232 |
| Accrued Expenses | 48,734 | 51,030 | 40,551 | 42,679 | 45,576 |
| TOTAL | $174,751 | $280,602 | $189,235 | $317,113 | $191,671 |
| Non-Current Liabilities | |||||
| Long Term Debt | 160,000 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 3,053 | 3,489 | 2,655 | 3,205 | 2,901 |
| Other Non-Current Liabilities | 318,954 | 348,311 | 349,131 | 350,057 | 349,860 |
| TOTAL | $478,954 | $358,549 | $349,131 | $366,665 | $365,912 |
| Total Liabilities | $653,705 | $639,151 | $538,366 | $683,778 | $557,583 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,286 | 55,291 | 54,887 | 54,614 | 54,614 |
| Common Shares | 344 | 340 | 337 | 328 | 323 |
| Retained earnings | 116,206 | 107,374 | 122,666 | 109,740 | 98,175 |
| Other shareholders' equity | 4,975 | 15,619 | 30,907 | 28,804 | 18,665 |
| TOTAL | $372,309 | $321,594 | $324,088 | $288,878 | $260,429 |
| Total Liabilities And Equity | $1,026,014 | $960,745 | $862,454 | $972,656 | $818,012 |